1-General Sessions and Opening Sessions B-roll
Brainomix Limited
Dr. Aparicio on SS25 4354018 Type 2 diabetes and dementia
Dr. Aparicio on SS25 4354018 controlling genetic risks with lifestyle changes
Dr. Aparicio on SS25 4354018 diabetes tipo 2 y demencia
Dr. Aparicio on SS25 4354018 enfoque en pacientes con diabetes tipo 2
Dr. Aparicio on SS25 4354018 high-risk group focus
Dr. Aparicio on SS25 4354018 incorporar habitos saludables en las comunidades
Dr. Aparicio on SS25 4354018 incorporating lifestyle interventions
Dr. Aparicio on SS25 4354018 Life's Essential 8 y diabetes tipo 2
Dr. Aparicio on SS25 4354018 tener control sobre los riesgos geneticos
Dr. Aparicio on SS25 4354018 Type 2 diabetes and Life's Essential 8
Dr. Fernandez-Mendoza on SS25 MP2275 artificial light and heart disease
Dr. Fernandez-Mendoza on SS25 MP2275 artificial light in neighborhoods
Dr. Fernandez-Mendoza on SS25 MP2275 contaminacion luminica y el estres
Dr. Fernandez-Mendoza on SS25 MP2275 first-of-its-kind observational study
Dr. Fernandez-Mendoza on SS25 MP2275 luz artificial y enfermedades cardiovasculares
Dr. Fernandez-Mendoza on SS25 MP2275 other potential factors
Dr. Fernandez-Mendoza on SS25 MP2275 otros posibles factores
Dr. Fernandez-Mendoza on SS25 MP2275 pasos para evitar la luz artificial
Dr. Fernandez-Mendoza on SS25 MP2275 regulaciones para luz artificial en barrios
Dr. Fernandez-Mendoza on SS25 MP2275 regulations needed for artificial light
Dr. Morris on SS25 MP2285 biomarkers studied
Dr. Morris on SS25 MP2285 Lpa biomarker
Dr. Morris on SS25 MP2285 Monitor CVD risk
Dr. Morris on SS25 MP2285 risk estimation exam
Dr. Morris on SS25 MP2285 study perspective
Dr. Ndumele on SS25 MP511 diabetes risk and GLP1 use
Dr. Ndumele on SS25 MP511 GLP1 therapies and CVD
Dr. Ndumele on SS25 MP511 GLP1 therapies impact
Dr. Ndumele on SS25 MP511 LE 8 optimal health
Dr. Ndumele on SS25 MP511 potential GLP1 impact in broader population
Dr. Ndumele on SS25 MP511 study limitations-next steps
Dr. Rodriguez on SS25 MP1504 aspirin usage and diabetes
Dr. Rodriguez on SS25 MP1504 aspirin usage recommendations for primary prevention
Dr. Rodriguez on SS25 MP1504 el uso de la aspirina y la diabetes
Dr. Rodriguez on SS25 MP1504 enfermedad cardiovascular y diabetes tipo 2
Dr. Rodriguez on SS25 MP1504 importancia de la salud personalizada
Dr. Rodriguez on SS25 MP1504 limitations in study
Dr. Rodriguez on SS25 MP1504 personalizing cardiovascular prevention
Dr. Rodriguez on SS25 MP1504 recomendaciones de aspirina en prevencion secundaria
Dr. Rodriguez on SS25 MP1504 recomendaciones para prevencion primaria
Dr. Rodriguez on SS25 MP1504 recommendations for aspirin in secondary prevention
Dr. Rodriguez on SS25 MP1504 se necesitan mas estudios
Dr. Rodriguez on SS25 MP1504 sorprendido por los efectos positivos de la aspirina
Dr. Rodriguez on SS25 MP1504 surprised on aspirin effects
Dr. Rodriguez on SS25 MP1504 type 2 diabetes and cardiovascular disease
Dr. St. Onge on SS25 MP2306 dietary supplement use
Dr. St. Onge on SS25 MP2306 getting proper diagnosis
Dr. St. Onge on SS25 MP2306 limitations-next steps
Dr. St. Onge on SS25 MP2306 melatonin long term use risks
Dr. St. Onge on SS25 MP2306 melatonin study perspective
Dr. St. Onge on SS25 MP2306 use of melatonin supplements
Dr. Testai on SS25 MP789 adding to existing evidence
Dr. Testai on SS25 MP789 amyloid cardiomyopathy and stroke risk
Dr. Testai on SS25 MP789 auricula izquierda y cardiomiopatia por amiloide
Dr. Testai on SS25 MP789 cardiomiopatia por amiloide y derrame cerebral
Dr. Testai on SS25 MP789 estilos de vida saludables
Dr. Testai on SS25 MP789 further testing is needed
Dr. Testai on SS25 MP789 prediccion de derrame cerebral
Dr. Testai on SS25 MP789 risk factors of stroke
Dr. Testai on SS25 MP789 risk-prediction tool and atrial chamber
Dr. Testai on SS25 MP789 se necesitan mas estudios
Henri Justino - Competition Winner
SS25 Conner Lecture - Dr. Stacey Rosen
Star Jones
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED